Clinical and basic studies of the effects of thymoma on myasthenia gravis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400091638

Enrollment

Unknown

Registered

2024-10-31

Start date

2024-05-28

Completion date

Unknown

Last updated

2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myasthenia gravis

Interventions

Case series:none

Eligibility

Sex/Gender

All

Age

10 Years to 100 Years

Inclusion criteria

Inclusion criteria: On the basis of the typical clinical features of MG (fluctuating muscle weakness), any of the following 3 points are satisfied: positive neostigmine test; positive for low-frequency repetitive electrical stimulation; Positive serum antibodies such as anti-AChR; MG patients diagnosed after exclusion of other diseases should also be required; Agree to participate in the study after knowing the content of the study

Exclusion criteria

Exclusion criteria: Patients with an unclear diagnosis; severe anxiety, depression, and schizophrenia; Poor adherence is expected

Design outcomes

Primary

Measure	Time frame
ADL score;	—

Countries

China

Contacts

Public ContactHongyu Zhou

West China Hospital, Sichuan University

zhouhy@scu.edu.cn+86 189 8060 1675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026